CXCL12 and neoplasm: In vitro experiments confirmed that blocking the CXCL12-CXCR4 signal axis activity by different molecular biology methods such as RNAi, small molecule inhibitors in breast cancer cells, could effectively reverse the malignant phenotype of the tumor cells [33–35].